Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 11/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.41 |
| ▸ | IDO1 | P14902 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.38 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | DAO | P14920 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8824002 | 0.81 | APP (0.46) | APPCYP3A4IDO1DAO | |
| SCHEMBL3353930 | 0.79 | IDO1 (0.47) | IDO1CYP1A2 | |
| SCHEMBL14899725 | 0.77 | TDP1 (0.44) | CYP3A4IDO1 | |
| SCHEMBL546541 | 0.76 | CYP1A2 (0.42) | CYP3A4IDO1CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL514628 | 0.73 | APP (0.47) | APPCYP3A4IDO1CYP1A2CYP2D6 | |
| SCHEMBL8824005 | 0.72 | APP (0.45) | APPCYP3A4IDO1CYP1A2CYP2D6 | |
| Methylene Chloride SCHEMBL28192144 | 0.71 | CYP1A2 (0.38) | CYP3A4IDO1CYP1A2CYP2D6 | |
| SCHEMBL13271320 | 0.70 | APP (0.44) | APPCYP3A4IDO1CYP1A2CYP2D6 | |
| SCHEMBL8007514 | 0.70 | APP (0.44) | APPCYP3A4IDO1CYP1A2CYP2D6 | |
| SCHEMBL18475586 | 0.69 | APP (1.00) | APPCYP3A4IDO1CYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2586778-A2 | Pyridazinone derivatives useful as glucan synthase inhibitors | Merck Sharp & Dohme Corp. (US) | 2013-05-01 | — | — | EP | disclosed |